351 results on '"Koehl U"'
Search Results
2. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
3. High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
4. Development of adaptive immune effector therapies in solid tumors
5. Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
6. Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
7. Cellular dynamics and their impact on outcome in patients with mantle cell lymphoma during treatment with chimeric antigen receptor (CAR) T cells
8. IS34 - WHAT COULD BE THE FUTURE OF GENETICALLY MODIFIED LYMPHOCYTES IN MDS?
9. T‐lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: A randomized controlled trial with sequential crossover
10. Urologie
11. Positive Selection of Hematopoietic Progenitor Cells for Autologous and Allogeneic Transplantation in Pediatric Patients with Solid Tumors and Leukemia
12. Cytotoxic Activity and Pharmacology of an Ara-CMP Prodrug in T-leukemic Sublines Resistant to Ara-C
13. Effect of Combined Treatment with 4-Hydroperoxycyclophosphamide and Fludarabine on Cytotoxicity and Repair of Damaged DNA
14. Kontinentes Appendixstoma — Modifikation der Mainz-Pouch Technik
15. Kontinente Harnableitung versus Neoblase — Differentialindikation
16. Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma
17. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
18. 1009P Current strategies of cell and gene therapy for solid tumors: Preliminary results of the joint international ESMO and EBMT Cell Therapy and Immunobiology Working Party questionnaire-based survey
19. The Impact of Rubella Virus Infection on a Secondary Inflammatory Response in Polarized Human Macrophages
20. T cells for suicide gene therapy: Activation, functionality and clinical relevance
21. Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations
22. Natürliche Killerzellen in der Leukämie- und Tumortherapie
23. Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis
24. IMMUNE RECONSTITUTION OF DENDRITIC CELLS SUBPOPULATIONS IN THE PERIPHERAL BLOOD AFTER PAEDIATRIC ALLOGENEIC STEM CELL TRANSPLANTATION: PH-P300
25. New insights to the MLL recombinome of acute leukemias
26. Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy
27. ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells
28. Effective treatment of leukemic cell lines with wt1 siRNA
29. Pharmacology of intracellular cytosine-arabinoside-5′-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes
30. Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+CD3+ count reconstitution is associated with survival
31. The MLL recombinome of acute leukemias
32. Editiorial: Modulation of Human Immune Parameters by Anticancer Therapies
33. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia
34. Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients
35. Use of natural killer cells in hematopoetic stem cell transplantation
36. 1088 - Immunotherapy: IN-DEPTH CHARACTERIZATION OF THE IMMUNE MICROENVIRONMENT OF PATIENTS UNDERGOING CAR T CELL THERAPY
37. Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes
38. Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience
39. No effect of antifungal compounds on functional properties of human antifungal T-helper type 1 cells
40. Age-Matched Dendritic Cell Subpopulations Reference Values in Childhood
41. Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia
42. Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
43. CD34+-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation
44. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation
45. Specific gene transfer to CD133-positive hematopoietic stem cells: OP-059
46. CELLULAR THERAPY IN HEMATOLOGICAL DISEASES: 3A-S12-01
47. Haplo-identical stem cell transplantation in children with relapsed neuroblastoma: O267
48. Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci
49. Correction of Chronic Granulomatous Disease by gene therapy: 237
50. CD3/CD19 depleted peripheral stem cells for matched unrelated donor in combination with a reduced intensity regimen - a new option in children lacking a matched sibling donor?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.